Scientific research drives innovation at Novartis. Our researchers work to push the boundaries of science, broaden our understanding of diseases and develop novel products with significant benefits for patients. We are focusing on faulty molecular pathways and therapeutic areas where we see the greatest unmet medical need and believe the scientific tools to address these needs are within reach.
The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis. Approximately 6 000 scientists and physicians prioritize work based on areas of greatest patient need and scientific understanding of disease.
Strategic alliances with academia and other companies strengthen our pipeline. We carry out research at Novartis locations and at partner institutions around the world:
Novartis Institutes for BioMedical Research (NIBR) – Cambridge, MA, USA (Headquarters)
NIBR Cambridge is located in the midst of multiple renowned academic research institutions and innovative biotech companies. The NIBR headquarters is home to research in the areas of oncology, ophthalmology, and cardiovascular and metabolic related diseases.
Novartis Institutes for BioMedical Research (NIBR) – Basel, Switzerland
Co-located with our corporate world headquarters, NIBR Basel is an integral part of the BioValley, Europe's biotechnology hub. Drug discovery here focuses on autoimmunity, transplantation, and inflammation, as well as musculoskeletal diseases, neuroscience, and oncology.
Novartis Institutes for BioMedical Research (NIBR) – East Hanover, NJ, USA
Located on the same campus as our US Pharmaceuticals Division headquarters, NIBR East Hanover focuses on research in cardiovascular and metabolic diseases. It is also home to the Novartis Knowledge Center (NKC) and information analysis, preclinical safety, and metabolism and pharmacokinetics groups.
Novartis Institutes for BioMedical Research (NIBR) – Emeryville, CA, USA
Located in the San Francisco Bay area, the NIBR Emeryville campus focuses on early discovery and research activities as a hub for infectious disease research, with additional expertise in structural and biophysical chemistry, computer-aided drug design and protein engineering across many disease areas.
Novartis Institutes for BioMedical Research (NIBR) – Shanghai, China
Novartis has an integrated biomedical Research & Development center in Shanghai’s Zhangjiang Hi-Tech Park in the midst of an emerging cluster of innovative academic, biotech and pharmaceutical research institutions. Research focuses on infectious causes of cancer primarily found in Asia and includes efforts in discovery chemistry and biomarker research.
The Genomics Institute of the Novartis Research Foundation (GNF) - La Jolla, CA, USA
Located in San Diego’s BioMedical research center, GNF is well-known for developing novel technology to drive cutting-edge drug discovery research, identify new biological pathways and discover mechanisms underlying human disease.
Novartis Institute for Tropical Diseases (NITD) - Emeryville, CA, USA
Dedicated to finding new medicines to treat neglected, infectious diseases. As a small-molecule drug discovery research institute, it combines the drug-discovery expertise and cutting-edge technologies of Novartis to fight infectious tropical diseases, including Dengue Fever, Human African Trypanosomiasis and Malaria.